This website uses cookies to improve your experience and help us improve the website. By continuing to use the site you agree to their use. Accept Learn more
Researchers at Imperial College London
Cancer survivors protocol committee
Secretariat and Executive Team
Researchers at Imperial College London maintain a central database of research papers on diet, nutrition, physical activity and cancer (including cancer survivors). The team, using the methodology of the Second Expert Report, prepares updated systematic literature reviews (SLRs) of the evidence as agreed with the Continuous Update Project (CUP) Secretariat and the Expert Panel. The review and collection of evidence is independent of the Expert Panel’s judgement of the evidence.
Teresa Norat, Principal Investigator
Leila Abar, Research Associate
Louise Abela, Research Associate
Dagfinn Aune, Research Associate
Margarita Cariolou, Research Associate
Doris Chan, Research Associate
Neesha Nanu, Research Associate
Jakub Sobiecki, Research Associate
Darren Greenwood, Statistical Advisor, University of Leeds
CUP peer reviewers are drawn from a range of appropriate backgrounds and from many different parts of the world. Two peer review stages are built into the process for the SLRs of updated evidence for the CUP – at the initial protocol stage and also when the updated SLRs were submitted in complete form.
Dr Christian Abnet , National Cancer Institute , US
Prof Peter Baade, Cancer Council Queensland, Australia
Dr Laura Baglietto, INSERM, France
Dr Franco Berrino, Istituto Nazionale dei Tumori , Italy
Dr Patrick Bradshaw, University of California, US
Dr Cristina Bosetti, Istituto di Ricerche Farmacologiche "Mario Negri", Italy
Dr Marie-Christine Boutron-Ruault, Gustave Roussy Institute, France
Dr Bas Bueno-de-Mesquita, National Institute of Public Health and the Environment (RIVM) , Netherlands
Dr Ben Cairns, University of Oxford , UK
Ms Yin Cao, Harvard TH Chan School of Public Health, US
Prof İsmail Çelik, Hacettepe Üniversitesi , Turkey
Dr Ock Chun, University of Connecticut, US
Dr Francoise Clavel-Chapelon, INSERM , France
Dr Helen Coleman, Queen's University Belfast, UK
Prof Michael Coory, Murdoch Children's Research Institute, Australia
Dr Brian Cox, University of Otago , New Zealand
Dr Amanda Cross, National Cancer Institute, US
Dr Meira Epplein, Vanderbilt University School of Medicine, US
Dr Andrew Flood, University of Minnesota , US (until June 2010)
Prof Elizabeth Fontham, Louisiana State University , New Orleans, US
Dr Silvia Franceschi , International Agency for Research on Cancer, France
Dr Neal Freedman, National Cancer Institute , US
Dr Lisa Gallicchio, Mercy Medical Center, US
Dr Milan Geybels, Maastricht University, Netherlands
Dr Carlos Gonzalez, Catalan Institute of Oncology, Spain
Dr Darren Greenwood, University of Leeds, UK
Dr Laura Hardie, University of Leeds, UK
Dr Michelle Harvie , University of Manchester, UK
Dr Anette Hjartåker, University of Olso, Norway
Dr Farhad Islami, Mount Sinai School of Medicine , US
Dr Paula Jakszyn, Instituto Catalan de Oncología , Spain
Dr Eleanor Kane, University of York, UK
Dr Ruth Keogh, University of Cambridge, UK
Prof Tim Key, University of Oxford , UK
Prof Suminori Kono, Kyushu University, Japan
Dr Petra Lahmann, University of Bremen, Germany
Dr Johanna Lampe, Fred Hutchinson Cancer Research Center, US
Dr Susanna Larsson, Karolinska Institutet, Sweden
Prof Michael Leitzmann, Regensburg University Medical Center , Germany (until October 2012)
Dr Albert Lowenfels, New York Medical College , US
Dr Jay Lubin, National Cancer Institute, US
Dr Steven Mark, University of Colorado, US
Prof John Mathers, University of Newcastle, UK
Prof Susan Mayne, Yale School of Public Health, US
Prof Marjorie McCullough, American Cancer Society, US
Mr Sam McClinton, NHS Grampian , UK
Dr Katherine McGlynn, National Cancer Institute, US
Dr Dominique Michaud, Brown University, US
Prof Anthony Miller, University of Toronto , Canada
Dr Dirk Moore, University of Medicine and Denistry of New Jersey, US
Prof Liam Murray, Queens University, Belfast, UK
Dr Christina Nagle , Queensland Institute for Medical Research , Australia
Dr Catherine Olsen, Queensland Institute for Medical Research , Australia
Dr Nicola Orsini, Karolinska Institutet, Sweden
Dr Yikyung Park, National Cancer Institute , US
Dr Jerry Polesel , Centro di Riferimento Oncologico, National Cancer Institute, Italy
Dr Sabina Rinaldi, International Agency for Research on Cancer, France
Dr Kim Robien, University of Minnesota, US
Dr Cheryl Rock, University of California , US
Dr Matteo Rota, Università degli Studi di Milano-Bicocca, Italy
Dr Sabrina Schlesinger, University of Kiel, Germany
Dr Leo Schouten, Maastricht University, Netherlands
Dr Jackilen Shannon, Oregon Institute of Occupational Health Sciences, US
Prof Linda Sharp, University of Newcastle, UK
Dr Xiao-Ou Shu, Vanderbilt University, US
Dr Meir Stampfer , Harvard School of Public Health, US
Prof Jonathan Sterne, University of Bristol, UK
Dr Rachael Stolzenberg-Solomon, National Cancer Institute, US
Dr Susan Sturgeon, University of Massachusetts, US
Prof Keitaro Tanaka, Saga University, Japan
Dr Sera Tort, Cochrane Lung Cancer Group, Spain
Prof Dimitrios Trichopoulos, Harvard School of Public Health, US
Dr Shoichiro Tsugane, National Cancer Center, Japan
Dr Cornelia Ulrich, Fred Hutchison Cancer Research Centre, US
Mrs Ros Wade, University of York, UK
Dr Penny Webb, Queensland Institute for Medical Research , Australia
Prof Elisabet Weiderpass Vainio, Karolinska Institutet, Sweden
Prof David Whiteman , Queensland Institute for Medical Research, Australia
Dr Elisabet Wirfalt , Lund University, Sweden
Dr Margaret Wright , University of Illinois, US
Dr Seiichiro Yamamoto, National Cancer Center Research Institute, Japan
Prof Weimin Ye, Karolinska Institutet, Sweden
Dr Kelly Yu, National Cancer Institute, US
Dr Jian-Min Yuan, University of Pittsburgh, US
Prof Maurice Zeegers, University of Birmingham, UK
Dr Antonella Zucchetto, Centro di Riferimento Oncologico, National Cancer Institute, Italy
Cancer survivors protocol committee, a special committee, chaired by Dr Lawrence Kushi, was convened to provide advice on how the research evidence on cancer survivors could best be captured. With the help of this committee a new protocol was developed which was used to review the evidence on breast cancer survivors. The members of the committee continue their involvement with this work by acting as advisers. You can view the protocol for reviewing the evidence for breast cancer survivors here. The breast cancer survivors report was published in October 2014.
Lawrence Kushi, Chair , Kaiser Permanente Oakland, CA, US
Marie-Christine Boutron-Ruault, INSERM, E3N-EPIC Group, Institut Gustave Roussy Villejuif, France
Bas Bueno-de-Mesquita , National Institute for Public Health and the Environment (RIVM), Netherlands
Josette Chor, School of Public Health and Primary Care , Chinese University of Hong Kong
Wendy Demark-Wahnefried, University of Alabama at Birmingham Comprehensive Cancer Center, US
Darren Greenwood, University of Leeds, UK
Michelle Harvie , University of Manchester, UK
The Secretariat is responsible for the day-to-day management of the CUP and reports to World Cancer Research Fund International’s Science Executive Team. The Continuous Update Project (CUP) is managed by World Cancer Research Fund International on behalf of the other charities within our network.
The Secretariat is led by Rachel Thompson, Head of Research Interpretation at World Cancer Research Fund International.
Emily Almond, Research Interpretation Assistant, World Cancer Research Fund International
Isobel Bandurek, Science Programme Manager (Research Interpretation), World Cancer Research Fund International
Susannah Brown, Senior Science Programme Manager (Research Evidence), World Cancer Research Fund International
Mariano Kälfors, CUP Project Manager, World Cancer Research Fund International
Giota Mitrou, Director of Research Funding and Science External Relations, World Cancer Research Fund International
Martin Wiseman, Medical and Scientific Advisor, World Cancer Research Fund International
The Secretariat reports to World Cancer Research Fund International’s Science Executive Team.
Kate Allen, Executive Director, Science & Public Affairs, World Cancer Research Fund International
Deirdre McGinley-Gieser, Senior Vice President for Programs and Strategic Planning, American Institute of Cancer Research